Making BCG vaccination programmes safer in the HIV era

The Lancet

Volumn 372, Issue 9641, 2008, Pages 786-787

  Mak, Tippi K ^a   Hesseling, Anneke C ^b,c   Hussey, Gregory D ^d   Cotton, Mark F ^b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 50649093776     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61318-5     Document Type: Note

References (15)

1. WHO. Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec 82 (2007) 193-196
2. Hesseling A.C., Marais B.J., Gie R.P., et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 25 (2007) 14-18
3. Trunz B.B., Fine P., and Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367 (2006) 1173-1180
4. Lotte A., Wasz-Hockert O., and Poisson N. Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc Lung Dis 63 (1988) 47-59
5. UNAIDS, WHO. AIDS epidemic update: December 2007: 1-60. http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf (accessed July 9, 2008).
6. Fallo A., Torrado L., Sánchez A., Cerqueiro C., Schargrodsky L., and López E. Delayed complications of Bacillus Calmette-Guérin (BCG) vaccination in HIV-infected children. International AIDS Society Conference, Rio de Janeiro, Brazil (July 24-27, 2005). www.ias-2005.org/planner/Presentations/ppt/749.ppt (accessed May 30, 2008).
7. WHO. Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group meeting, WHO HQ, Geneva, Switzerland (April 10-11, 2008). http://www.who.int/hiv/pub/paediatric/WHO_Paediatric_ART_guideline_rev_mreport_2008.pdf (accessed June 15, 2008).
8. Violari A., Cotton M., Gibb D., et al., on behalf of the CHER Study Team. Antiretroviral therapy initiated before 12 weeks of age reduces early mortality in young HIV-infected infants: evidence from the Children with HIV Early Antiretroivral Therapy (CHER) Study. Presentation at the 4th International AIDS Society Conference; July 22-25, 2007; Sydney, Australia. www.ias2007.org/pag/PSession.aspx?s=150 (accessed July 9, 2008).
9. WHO/UNAIDS. Guidance on provider-initiated HIV testing and counseling in health facilities. World Health Organization, Geneva, Switzerland (2007). www.who.int/hiv/pub/guidelines/9789241595568_en.pdf (accessed May 30, 2008).
10. Chersich M.F., Luchters S.M., Othigo M.J., Yard E., Mandaliya K., and Temmerman M. HIV testing and counselling for women attending child health clinics: an opportunity for entry to prevent mother-to-child transmission and HIV treatment. Int J STD AIDS 19 (2008) 42-46
11. Rollins N., Little K., Mzolo S., Horwood C., and Newell M.L. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS 21 (2007) 1341-1347
12. Salisbury D, Ramsay M, Noakes K, eds. Chapter 32: Tuberculosis. Immunisation against infectious disease: the Green Book, 3rd edn. 2006: 391-408. http://www.dh.gov.uk/en/Publichealth/Healthprotection/Immunisation/Greenbook/DH_4097254, (accessed May 30, 2008).
13. Infuso A., Falzon D., and on behalf of the EuroTB network. European survey of BCG vaccination policies and surveillance in children, 2005. Euro Surveill 11 (2006) 6-11
14. Enserink M. Public health. In the HIV era, an old TB vaccine causes new problems. Science 318 (2007) 1059
15. Weidle P.J., Wamai N., Solberg P., et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 368 (2006) 1587-1594